Skip directly to content

Prevnar 13® is Recommended by Doctors at the CDC

Doctors at the Centers for Disease Control and Prevention (CDC) recommend that all children 2 months to 5 years of age receive Prevnar 13®.

CDC and AAP Recommendations

To help prevent invasive pneumococcal disease (IPD) in infants and young children, the CDC Advisory Committee on Immunization Practices (ACIP) and the American Academy of Pediatrics (AAP) recommend 4 doses of Prevnar 13® at 2, 4, 6 and 12-15 months of age.

View the vaccination schedule for Prevnar 13®.

Learn more about the AAP immunization recommendation, visit

Talk to your child's doctor about the risks and benefits of Prevnar 13®. Only a health care provider can decide if Prevnar 13® is right for your child.


You Are Now Leaving

Links to all outside sites are provided as a resource to our visitors. Pfizer accepts no responsibility for the content of sites that are not owned and operated by Pfizer.

Continue >>

PREVNAR® and PREVNAR 13® are registered trademarks of Wyeth LLC.

Manufactured by Wyeth Pharmaceuticals Inc. Marketed by Pfizer Inc. PSP625800-01 © 2014 Pfizer Inc.
All rights reserved. May 2014

This site is intended only for residents of the United States.
All rights reserved. Please read our Privacy Policy and Terms and Conditions.

The product information provided in this site is intended for residents of the United States. The products discussed herein may have different product labeling in different countries.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.